Nov 11 (Reuters) – Ascletis Pharma: * SUBMITS IND APPLICATION TO U.S. FDA FOR ASC30_39 FDC FOR OBESITY Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)